Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s ...

Biogen enhances its portfolio and margins amidst market challenges and competition. Click here to find out why BIIB stock is ...

Patients with Spinal Muscular Atrophy (SMA) are hopeful of getting access to generic versions of Roche’s patented drug ...

Basically, a brand-name drug company settles a patent infringement lawsuit by paying cash or transferring something else of ...

Commonsense management measures can help keep arthritic horses comfortable and sound even in the coldest weather.

Last year, the osteoporosis treatment drug Prolia (denosumab) generated revenue of 9 trillion won globally, and its patent has sequentially expired in major countries since last month ...

Last year, Prolia (generic name denosumab), a treatment for osteoporosis that generated an annual revenue of 9 trillion won worldwide, saw its patent sequentially expire in major countries ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has entered into a settlement agreement with Annora Pharma ...

Johnson & Johnson’s Stelara, Regeneron’s Eylea and Amgen’s Prolia are just some of the drugs facing off against new ...

An analysis by Pharmarack, a market research firm, showed that 226 vildagliptin (anti-diabetic) brands are now available in ...